Altering T-cell activation by targeting the multidomain tyrosine kinase Itk

Trends Immunol. 2003 May;24(5):249-53. doi: 10.1016/s1471-4906(03)00071-1.

Authors

Steven B Kanner¹, Juan J Perez-Villar

Affiliation

¹ Immunology and Oncology Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, NJ 08543, USA.

PMID: 12738418
DOI: 10.1016/s1471-4906(03)00071-1

No abstract available

Publication types

Review

MeSH terms

Animals
Humans
Lymphocyte Activation / immunology*
Protein-Tyrosine Kinases / chemistry
Protein-Tyrosine Kinases / physiology*
Signal Transduction / immunology*
T-Lymphocytes / immunology*

Substances

Protein-Tyrosine Kinases
emt protein-tyrosine kinase